Back to results
US 2006/0223870 A1Published application
Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
AssigneeTakeda Pharmaceutical Company Limited
InventorsKazuhiro Doken, Tetsuya Kawano, Hiroyoshi Koyama, Naoru Hamaguchi
Life of this patent
Estimating the term…
Abstract
A solid preparation useful as a diabetes-treating agent or the like and excellent in the dissolution properties of an insulin sensitizer and an insulin secretagogue, which comprises an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester is provided.
Claims6
A solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester.
A solid preparation comprising pioglitazone hydrochloride, glimepiride and Polysorbate 80.
Dependencies are inferred from the claim text.